- CVS Health (CVS, Financial) anticipates a strong Q1 performance with a projected EPS increase of 27%.
- Analyst consensus indicates a favorable outlook, showing an "Outperform" status.
- CVS is currently undervalued according to GuruFocus metrics, suggesting significant upside potential.
Upcoming Earnings Report: CVS Health Shows Promising Growth
As CVS Health (CVS) gears up for its first-quarter earnings announcement on May 1, investors are optimistic about the company's financial health. CVS projects a remarkable 27% increase in earnings per share (EPS), reaching $1.67, alongside a 5.6% revenue growth, totaling $93.37 billion. Analysts attribute this robust performance to CVS's recession-resistant business model and a recent uplift in Medicare Advantage payments.
Wall Street Analysts' Insight on CVS
The market consensus from 24 analysts sets a one-year average price target for CVS Health Corp at $74.84, with projections soaring as high as $90.00 and dipping to a low of $60.00. This suggests a potential upside of 12.63% from the current trading price of $66.45. For a comprehensive overview of these estimates, please visit the CVS Health Corp (CVS, Financial) Forecast page.
Further backing the positive sentiment, 29 brokerage firms collectively recommend an "Outperform" rating for CVS Health Corp with an average recommendation score of 2.2. In this rating system, 1 represents a Strong Buy, while 5 indicates a Sell.
Assessing CVS's True Value
According to GuruFocus estimates, the projected GF Value for CVS Health Corp in a year's time is approximately $87.79. This valuation suggests a potential upside of 32.11% from its current price of $66.45. The GF Value metric reflects the stock's fair price based on its historical trading multiples, past growth, and future performance projections. Investors seeking a detailed analysis should explore the CVS Health Corp (CVS, Financial) Summary page.
In summary, CVS Health stands as a compelling investment opportunity for those eyeing long-term growth within a stable market sector.